PTI NEWS

Dr Reddy's Lab recalls Famotidine tablets from US market

Hyderabad, Oct 20 (PTI) Dr Reddy's Laboratories hasinitiated voluntarily recall of over half a million Famotidinetablets bottles from the US market...

From our online archive

Hyderabad, Oct 20 (PTI) Dr Reddy's Laboratories hasinitiated voluntarily recall of over half a million Famotidinetablets bottles from the US market as the drug failedimpurities or degradation specifications.

According to a notification put up by the US Food andDrug Administration, the recall is being made under'Class-III' classification, which is described as 'a situationin which use of or exposure to a violative product is notlikely to cause adverse health consequences'.

"Failed impurities/degradation specifications:Famotodine has an out of specification result for anindividual related substance observed during routine stabilitytesting of a batch for related substances -impurity 8 at 24month stability interval," the notification said on thereasons for recall.

As many as 5,69,376 bottles of Famotidine tablets, 10mg belonging to multiple lots packaged in 30-count, are beingrecalled nationwide.

The drug is an over-the-counter (OTC) product used totreat and prevent ulcers in stomach and intestines. PTI GDKGK.

This is unedited, unformatted feed from the Press Trust of India wire.

Trump says war will end 'very quickly' as Iran wants to make deal 'so badly'; predicts 'oil prices to plummet'

Satheesan defies Kharge as portfolio row dampens UDF victory euphoria

US lost 42 aircraft, including fighter jets, MQ-9 Reaper drones in Iran war, says report

DRDO completes final trials of drone launched missile for tanks, aerial targets

Kharge's lunch meeting sparks buzz over Karnataka leadership change, cabinet reshuffle talks

SCROLL FOR NEXT